Pere Ma Appointed As New CEO Of Suanfarma

MADRID, April 22, 2025 /CNW/ -- Suanfarma, a global company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and high-value CDMO services for the health industry, has announced the appointment of Pere Mañé Godina as its new Chief Executive Officer (CEO). This marks the beginning of a new chapter for the company, focused on industrial consolidation, sustainable innovation, and global expansion.

With a career spanning more than 30 years, Pere has held technical and strategic executive positions at leading pharmaceutical companies such as Uquifa, Boehringer Ingelheim, and Esteve Química (Esteve Group). His experience ranges from technical and operational roles to executive positions such as General Manager and Group Chief Industrial Operations Officer.

Most recently, Pere played a key role in the industrial transformation of Esteve, positioning its chemical division as a global benchmark. Under his leadership, the company was recognized as CDMO of the Year – Small Molecules at the DCAT 2025 Leadership Awards, one of the industry's most prestigious honors.

This appointment aligns with Suanfarma's long-term strategic vision. Carlos Alonso, interim CEO since October 2024, will ensure a smooth transition and will remain with the company as Executive Chairman:

"We are confident that Pere's deep sector knowledge, strategic mindset, and leadership experience will be instrumental in strengthening Suanfarma's market position and continuing to deliver high-value solutions to our customers and partners."

Pere's arrival brings decisive momentum to Suanfarma's growth journey. His focus on operational excellence, advanced CDMO capabilities, and strong strategic partnerships will guide the company through its next phase with the following objectives:

Streamlining industrial operations and integrating new technologies
Strengthening relationships with global clients and key suppliers
Accelerating international expansion
Fostering a culture of innovation and sustainability

In the words of Pere Mañé Godina, "Suanfarma has all the elements to lead the future of the industry: a solid foundation, a strong industrial platform, and a high-value international network supported by an exceptional team. I'm excited to begin this new chapter and work together to keep delivering innovative, efficient, and sustainable solutions to our clients."

About Suanfarma

Founded in 1993, Suanfarma is a B2B partner in the life sciences sector, committed to health and innovation through the sustainable development, manufacturing, and distribution of high-quality pharmaceutical ingredients. With presence in over 70 countries, it has been part of the healthcare-focused investment firm Archimed since 2021.

Photo: https://mma.prnewswire.com/media/2669173/Suanfarma.jpg

Logo: https://mma.prnewswire.com/media/2666505/SUANFARMA_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/pere-mane-appointed-as-new-ceo-of-suanfarma-302433513.html

SOURCE Suanfarma

Frequently Asked Questions

Who is the new CEO of Suanfarma?

Pere Mañé Godina has been appointed as the new Chief Executive Officer (CEO) of Suanfarma.

What is Suanfarma's strategic focus under the new CEO?

Suanfarma's strategic focus includes industrial consolidation, sustainable innovation, and global expansion within the pharmaceutical industry.

What is Suanfarma's main business?

Suanfarma is a global company specializing in the development, production, and commercialization of active pharmaceutical ingredients (APIs) and high-value CDMO services for the health industry.

First published on Tue, Apr 22, 2025

Liked what you read? That’s only the tip of the tech iceberg!

Explore our vast collection of tech articles including introductory guides, product reviews, trends and more, stay up to date with the latest news, relish thought-provoking interviews and the hottest AI blogs, and tickle your funny bone with hilarious tech memes!

Plus, get access to branded insights from industry-leading global brands through informative white papers, engaging case studies, in-depth reports, enlightening videos and exciting events and webinars.

Dive into TechDogs' treasure trove today and Know Your World of technology like never before!

Disclaimer - Reference to any specific product, software or entity does not constitute an endorsement or recommendation by TechDogs nor should any data or content published be relied upon. The views expressed by TechDogs' members and guests are their own and their appearance on our site does not imply an endorsement of them or any entity they represent. Views and opinions expressed by TechDogs' Authors are those of the Authors and do not necessarily reflect the view of TechDogs or any of its officials. While we aim to provide valuable and helpful information, some content on TechDogs' site may not have been thoroughly reviewed for every detail or aspect. We encourage users to verify any information independently where necessary.

Tags:

Suanfarma Pere Mañé Godina CEO Pharmaceutical Technology CDMO APIs Active Pharmaceutical Ingredients Health Industry Industrial Consolidation Sustainable Innovation Global Expansion

Join The Discussion

- Promoted By TechDogs -

Pharmaceutical Technology